论文部分内容阅读
本文分析了 80例不同年龄肺结核咯血的临床特点和咯血对人体的危害性 ,并讨论了肺结核咯血诊治中有关问题。针对肺结核咯血的发病机理和如何选用止血药物来达到迅速止血之目的。方法 将 80例肺结核咯血病人分为垂体后叶素单用组和垂体后叶素和酚妥拉明联用组。结果 经临床使用对比 ,发现垂体后叶素酚妥拉明联用组比单用垂体后叶素组有显著的优越性。单用垂体后叶素组 1 /4的病人疗效差 ,平均在 1 4天左右才能止血 ,有效治愈率 75%。而垂体后叶素酚妥拉明联用组平均8天左右即可止血 ,有效治愈率为 95 %。结论 垂体后叶素酚妥拉明联用具有适应症广、止血块、病程短 ,疗效好和副作用小等优点
This article analyzes the clinical characteristics of 80 cases of tuberculosis and hemoptysis of different ages and the dangers of hemoptysis on the human body, and discusses the related problems in the diagnosis and treatment of pulmonary tuberculosis hemoptysis. For the pathogenesis of tuberculosis hemoptysis and how to choose the hemostatic drugs to achieve the purpose of rapid bleeding. Methods Eighty pulmonary tuberculosis patients with hemoptysis were divided into three groups: pituitrin single group and pituitrin combined with phentolamine group. Results Clinical comparison showed that pituitrin phentolamine combination group than the pituitrin group alone had significant advantages. Patients with pituitrin only 1/4 poor efficacy, an average of about 14 days to stop bleeding, the effective cure rate of 75%. The pituitrin phentolamine combined with an average of about 8 days to stop bleeding, the effective cure rate was 95%. Conclusion Pituitrin phentolamine combined with indications of wide, hemostatic block, short course, good curative effect and the advantages of small side effects